Dr. Benjamin Kelmendi is an Associate Research Scientist at Yale University School of Medicine, Department of Psychiatry.Dr. Kelmendi’s interests lie in the area of clinical research aiming to understand the mechanism of symptoms that characterize Obsessive-Compulsive Disorder and Posttraumatic Stress Disorder with the ultimate goal of developing new understandings and better treatments.In parallel, he is interested in elucidating the neurobiological mechanisms of pharmacological interventions that produce acute clinical effects such as MDMA, Psilocybin, and Ketamine using various methodological tools: fMRI, MRS, EEG, genetics, and neurocognitive testing.